UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in AUPH — Aurinia Pharmaceuticals Inc.
CIK 861177
NEW YORK, NY
Position in AUPH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,897,360
+$440,509 QoQ
Shares Held
229,662
-1.5% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 279 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 49%
Shared 0%
None 51%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. AUPH ranks #73 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in AUPH
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,897,360 | 229,662 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,456,851 | 233,256 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,815 | 490 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,414,843 | 218,538 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,757,102 | 443,578 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,279,541 | 159,147 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $3,265,789 | 363,674 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,187,665 | 298,454 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,860,784 | 325,882 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $802,339 | 160,148 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,439,729 | 160,148 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,147,635 | 147,701 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,438,988 | 148,656 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,629,267 | 148,656 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $615,075 | 142,379 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $682,891 | 90,810 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,003,390 | 99,840 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $652,920 | 52,740 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,235,167 | 141,459 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $271,778 | 12,281 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $1,833,308 | 141,459 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,560,264 | 120,159 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,548,392 | 111,959 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $1,462,085 | 99,259 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,289,583 | 79,359 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,065,890 | 73,459 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||